Catalyst Wire Dossier Catalyst Wire Dossier

Delta-9-tetrahydrocannabinol (Δ9-THC)

tetrahydrocannabinol
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Delta-9-tetrahydrocannabinol (Δ9-THC), covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults [Phase 1]

See pricing